6.490USD+6.57%Mkt Cap: 209.24M USDP/E: —Last update: 2026-05-26
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap209.24M USD
Enterprise Value164.71M USD
Revenue (TTM)1.95M USD
Gross Profit2.30M USD
Net Income (TTM)-50.22M USD
Revenue/Share0.0600 USD
Last Price6.490 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees55
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.54
PEG—
EV/EBITDA-5.06
EV/Revenue84.51
P/S97.42
P/B-5.36
EPS (TTM)-1.51
EPS (Forward)-0.78
52W Range
2.33067% of range8.510
52W High8.510 USD
52W Low2.330 USD
Profitability
Gross Margin56.67%
Oper. Margin-32284.38%
EBITDA Margin0.00%
Profit Margin-1238.52%
ROE159.62%
ROA-194.99%
Growth
Revenue Growth-98.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.18M USD
CapEx (TTM)3.19M USD
FCF Margin-809.11%
FCF Yield-7.54%
Net Debt-25.13M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity-0.11
Current Ratio2.54
Quick Ratio2.36
Book Value/Sh-1.0970 USD
Cash/Share0.8730 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 25, 2023
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)8.333 USD
Target Range4.000 USD – 12.00 USD
# Analysts3
Ownership
Shares Out.32.29M
Float10.08M
Insiders20.02%
Institutions61.45%
Short Interest
Short Ratio1.7d
Short % Float4.50%
Short % Out.2.21%
Shares Short713.24K
Short (prev mo.)368.28K
Technical
SMA 504.257 (+52.4%)
SMA 2004.902 (+32.4%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)466.26K
Avg Vol (10d)419.96K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—